Compare RDHL & CREV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RDHL | CREV |
|---|---|---|
| Founded | 2009 | 2007 |
| Country | Israel | Australia |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8M | 3.1M |
| IPO Year | N/A | N/A |
| Metric | RDHL | CREV |
|---|---|---|
| Price | $1.13 | $2.50 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 66.1K | ★ 141.7K |
| Earning Date | 09-05-2025 | 01-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $9,550,000.00 | ★ $47,677,475.00 |
| Revenue This Year | $381.91 | $40.32 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 157.62 | 86.77 |
| 52 Week Low | $1.01 | $1.48 |
| 52 Week High | $7.00 | $9.45 |
| Indicator | RDHL | CREV |
|---|---|---|
| Relative Strength Index (RSI) | 44.31 | 56.65 |
| Support Level | $1.10 | $1.57 |
| Resistance Level | $1.23 | $1.77 |
| Average True Range (ATR) | 0.05 | 0.30 |
| MACD | 0.00 | 0.12 |
| Stochastic Oscillator | 28.25 | 69.96 |
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.
Carbon Revolution PLC is an Australian-based technology company manufacturing carbon fiber wheels. It is an OEM supplier and a world-wide manufacturer of lightweight technology carbon fibre wheels to the automotive industry. The Company supplies wheels to OEMs across the globe for luxury and high-performance vehicles and SUVs, and is developing wheels for electric vehicles under contract for its OEM customers. The company generates maximum revenue Internationally.